Company Search:
Advanced Search
Sponsored Links
Angiogenex Inc Company Snapshot
Angiogenex Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Angiogenex Inc with three other companies in this sector in UNITED STATES : International Stem Cell Corporation (2007 sales of $38,764.00 of which 100% was Therapeutic Product and Development), Metabolic Research, Inc. ($54,026.00 of which 100% was Online Information Services), and Abeona Therapeutics Inc ($57,000.00 of which 100% was Advanced polymer).

Sales Analysis.
  Stock Performance Chart for Angiogenex Inc
  Stock Data: Recent Stock Performance:
  Current Price (6/2/2021): .11
(Figures in U.S. Dollars)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
Angiogenex Inc Key Data:
  Ticker: AGGX Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2007 Sales 50,000
(Year Ending Jan 2008).
  Currency: U.S. Dollars Market Cap: 3,342,533
  Fiscal Yr Ends: December Shares Outstanding: 30,386,667
  Share Type: Closely Held Shares: 16,037,677
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.